JOCELYN LAPORTA: Open Payments
NPI 1285493296 · GLOVERSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$301 in 15 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $172 · 2025 $301
Food & beverage: $301
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $89 |
| Novo Nordisk Inc | 3 | $59 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $42 |
| Verona Pharma, Inc. | 1 | $33 |
| Ardelyx, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $14 |
Products named: VRAYLAR, Rybelsus, XIFAXAN, UBRELVY, Ohtuvayre, IBSRELA, JARDIANCE, TRELEGY ELLIPTA.
Industry payments across NY — which companies pay providers there.
